Department of Obstetrics and Gynaecology, Martini Hospital, Groningen, the Netherlands.
Department of Obstetrics and Gynaecology, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
BJOG. 2015 Jun;122(7):1022-30. doi: 10.1111/1471-0528.13325. Epub 2015 Mar 9.
To compare transvaginal prolapse repair combined with midurethral sling (MUS) versus prolapse repair only.
Multi-centre randomised trial.
Fourteen teaching hospitals in the Netherlands.
Women with symptomatic stage two or greater pelvic organ prolapse (POP), and subjective or objective stress urinary incontinence (SUI) without prolapse reduction.
Women were randomly assigned to undergo vaginal prolapse repair with or without MUS. Analysis was according to intention to treat.
The primary outcome at 12 months' follow-up was the absence of urinary incontinence (UI) assessed with the Urogenital Distress Inventory and treatment for SUI or overactive bladder. Secondary outcomes included complications.
One hundred and thirty-four women were analysed at 12 months' follow-up (63 in MUS and 71 in control group). More women in the MUS group reported the absence of UI and SUI; respectively 62% versus 30% UI (relative risk [RR] 2.09; 95% confidence interval [CI] 1.39-3.15) and 78% versus 39% SUI (RR 1.97; 95% CI 1.44-2.71). Fewer women underwent treatment for postoperative SUI in the MUS group (10% versus 37%; RR 0.26; 95% CI 0.11-0.59). In the control group, 12 women (17%) underwent MUS after prolapse surgery versus none in the MUS group. Severe complications were more common in the MUS group, but the difference was not statistically significant (16% versus 6%; RR 2.82; 95% CI 0.93-8.54).
Women with prolapse and co-existing SUI are less likely to have SUI after transvaginal prolapse repair with MUS compared with prolapse repair only. However, only 17% of the women undergoing POP surgery needed additional MUS. A well-informed decision balancing risks and benefits of both strategies should be tailored to individual women.
比较经阴道脱垂修复术联合中尿道吊带术(MUS)与单纯脱垂修复术的效果。
多中心随机试验。
荷兰 14 所教学医院。
患有症状性 II 期或更严重盆腔器官脱垂(POP),且伴有主观或客观压力性尿失禁(SUI)但无脱垂减轻的女性。
将女性随机分为经阴道脱垂修复术联合或不联合 MUS 治疗组。分析采用意向治疗。
12 个月随访时的主要结局为采用尿失禁问卷评估的无尿失禁(UI)和 SUI 的治疗或治疗过的膀胱过度活动症。次要结局包括并发症。
134 名女性在 12 个月时进行了分析(MUS 组 63 名,对照组 71 名)。MUS 组中更多的女性报告 UI 和 SUI 消失;UI 分别为 62%比 30%(相对风险[RR]2.09;95%置信区间[CI]1.39-3.15),SUI 分别为 78%比 39%(RR 1.97;95% CI 1.44-2.71)。MUS 组术后 SUI 治疗的女性较少(10%比 37%;RR 0.26;95% CI 0.11-0.59)。在对照组中,12 名(17%)女性在脱垂手术后接受了 MUS,而 MUS 组中没有。MUS 组严重并发症更为常见,但差异无统计学意义(16%比 6%;RR 2.82;95% CI 0.93-8.54)。
与单纯脱垂修复术相比,经阴道脱垂修复术联合 MUS 治疗可使患有脱垂和共存 SUI 的女性在术后更不易发生 SUI。然而,只有 17%的接受 POP 手术的女性需要额外的 MUS。应根据个体女性的情况,制定知情决策,权衡两种策略的风险和获益。